Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?
about
Trachoma and the need for a coordinated community-wide response: a case-based studyCommunity risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trialSerology for trachoma surveillance after cessation of mass drug administrationThe Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic TreatmentBlinding trachoma in postconflict southern SudanThe natural history of trachoma infection and disease in a Gambian cohort with frequent follow-upEstimating household and community transmission of ocular Chlamydia trachomatis.Mass antibiotic treatment alone does not eliminate ocular chlamydial infection.Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachomaProfound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communitiesTrachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.Correlation of clinical trachoma and infection in Aboriginal communitiesRisk factors for ocular chlamydia after three mass azithromycin distributions.Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting.Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines.Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger.Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributionsBlinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive DiseaseMeasuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis.Can corneal pannus with trachomatous inflammation--follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?Epidemiology and control of trachoma: systematic review.Conjunctival infection with Chlamydia trachomatis in sexual partners of patients with adult inclusion conjunctivitis.Estimating community prevalence of ocular Chlamydia trachomatis infection using pooled polymerase chain reaction testing.Clinical and microbiological diagnosis of trachoma in children living in rural areas in the district of Attock, Punjab, Pakistan.Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.Prevalence of Chlamydia trachomatis-Specific Antibodies before and after Mass Drug Administration for Trachoma in Community-Wide Surveys of Four Communities in Nepal.
P2860
Q25257216-D2C87A9B-2599-4A18-83BF-5D74F9113166Q28482497-E3FA3577-BC9A-4CF0-B50A-4917D059DB01Q28543658-53278C21-0913-4323-AC74-47F50C25754FQ28552982-4625561A-51F7-4132-B6E5-5F7FB4686A22Q28764681-9D9BFC29-0B9B-413B-867C-2D640A479D68Q33388677-E6BB02B6-5807-41DD-8EB4-335BBA96DC60Q33424445-A65C18A3-AAD9-4930-9CED-71116D7224ECQ33424456-A6FFC38D-16BC-47DB-A1E4-48D254B95123Q33520204-62D0D36A-F1B0-46F7-ABB4-720372AF18C7Q33693683-4877ED41-FF16-4D02-971B-7D8487D168A5Q33721962-7B718785-6C07-4136-865E-98BDFE201BC0Q33745187-E113F292-D0B8-4566-AE11-4F4F015984F3Q33851430-622F2419-B57F-41EF-8A60-C479ADFC770FQ34105280-E90545BF-A9BF-4BE3-BC16-40E642D8A5B1Q34607259-4C7B8B2A-0137-4E66-8D6B-0FEB10FE4BB0Q35221283-7E088D58-3045-479E-A20D-74296B70F4A3Q35598027-39D7E9BA-FF25-4BC4-8ACA-F5C0A69CF3E3Q35762854-B9369436-4475-4AC0-987F-A57C3F231A13Q35763113-081318D9-CAE1-47C0-8DA1-8068D3B454DFQ35797198-9D747A1B-FA69-4E8F-868C-F21FC7510E80Q36092398-A417FD3A-D823-45DA-84BD-FE1144EA8819Q36378603-7EC779D1-33E8-420F-A9EE-99508DEEE2FAQ36508898-3CEBA3E0-388A-46D9-8E21-1E229FA20C97Q37165258-7CDE865F-C270-46E0-8ADA-379701423CC3Q37844703-0D2EAB65-3BC7-42B0-93A6-42A226844E5EQ37844746-FEBA3235-1D1B-427E-9269-A7DA2BB0CD7EQ37861092-FAFE79E6-EBFE-43FA-AB49-E8FDAB609855Q40045638-B190E3BA-8D8E-4257-9E37-A8EC1B5B6EC2Q44059336-F502D8DC-B2C5-4A9C-A90F-684438E8BB9B
P2860
Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinical examination and labor ...... at are they really telling us?
@ast
Clinical examination and labor ...... at are they really telling us?
@en
type
label
Clinical examination and labor ...... at are they really telling us?
@ast
Clinical examination and labor ...... at are they really telling us?
@en
prefLabel
Clinical examination and labor ...... at are they really telling us?
@ast
Clinical examination and labor ...... at are they really telling us?
@en
P1476
Clinical examination and labor ...... at are they really telling us?
@en
P2093
Heathcote R Wright
P304
P356
10.1016/S1473-3099(05)70116-X
P577
2005-05-01T00:00:00Z